Natural Product Research · 2009 · 64 citations · 24 references
MedicineEndocrinologyPharmacologyBiochemical PharmacologyDiabetologyNeuropharmacologyDiabetes PharmacotherapyEndocrine PharmacologyOral Antidiabetic AgentsAntidiabetic ActivityAntidiabetic Drug TherapyBlood Glucose RegulationDiabetes Mellitus PathophysiologyGlucose Metabolism EffectsGlucose-stimulated Insulin SecretionInsulin Secretion EnhancementOral Antidiabetic Therapy
We evaluated the antihyperglycaemic effect of scoparic acid D (SAD), a diterpenoid isolated from the ethanol extract of Scoparia dulcis in streptozotocin (STZ)-induced diabetic male Wistar rats. SAD was administered orally at a dose of 10, 20 and 40 mg kg(-1) bodyweight for 15 days. At the end of the experimental period, the SAD-treated STZ diabetic rats showed decreased levels of glucose as compared with diabetic control rats. The improvement in blood glucose levels of SAD-treated rats was associated with a significant increase in plasma insulin levels. SAD at a dose of 20 mg kg(-1) bodyweight exhibited a significant effect when compared with other doses. Further, the effect of SAD was tested on STZ-treated rat insulinoma cell lines (RINm5F cells) and isolated islets in vitro. SAD at a dose of 20 microg mL(-1) evoked two-fold stimulation of insulin secretion from isolated islets, indicating its insulin secretagogue activity. Further, SAD protected STZ-mediated cytotoxicity and nitric oxide (NO) production in RINm5F cells. The present study thus confirms the antihyperglycaemic effect of SAD and also demonstrated the consistently strong cytoprotective properties of SAD.
24
Biochemistry and molecular cell biology of diabetic complications
Michael Brownlee · Nature · 2001 · 9K citations
Enzyme immunoassay for intact human insulin in serum or plasma
Lennart Andersen, Bo Dinesen, P N Jørgensen et al. · Clinical Chemistry · 1993 · 524 citations